Locations:
Search
This conference will provide disease specific, evidence-based, high quality and practical talks and exchanges to update the participants on the latest advances in the diagnosis and multidisciplinary management of the most prevalent cancers at all stages of disease and treatment.
The conference will cater to medical oncologists, hematologists, radiation oncologists, and other healthcare professionals involved in the diagnosis, prevention and treatment of cancer. Current, new and future advances in cancer care will be discussed. The role of emerging technologies, supportive care and non-pharmacologic care of the cancer patient will be addressed. In addition to didactic lectures, case-based discussions will address the more challenging situations faced by cancer caregivers.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Describe progress in the prevention, diagnosis, and treatment of cancer
Discuss the latest innovations in digital technologies and genomics
Review recent updates in cancer research in a concise format, allowing translation of new knowledge into better care for patients with cancer
This activity is targeted to a national and international audience of practitioners and health care professionals, and is designed for physicians, fellows, residents, pharmacists, researchers, advance practice providers and nurses in the fields of medical, surgical and radiation oncology; palliative care; pathology; and pharmacology.
Register online: www.ccfcme.org/cccc2024
For more information, visit Cleveland Clinic Florida ConsultQD. Subscribe to the Florida Physician Newsletter.
Additionally, follow us on X (formerly Twitter), Facebook, and LinkedIn.
Advertisement
Advertisement
Nonthermal technique reduces bleeding and perforation risk
Standardizing a minimally invasive approach for Barrett’s Esophagus and Esophageal Cancer
PSMA-targeted therapy for metastatic prostate cancer now offered at Cleveland Clinic Weston Hospital
Nationally recognized urologic oncologist offers vision for growth, innovation, and excellence
Noninvasive modality gains ground in United States for patients with early-to-moderate disease
Cleveland Clinic Weston Hospital’s collaborative model elevates care for complex lung diseases
Interventional pulmonologists at Cleveland Clinic Indian River Hospital use robotic technology to reach small peripheral lung nodules
Trained in the use of multiple focal therapies for prostate cancer, Dr. Jamil Syed recommends HIFU for certain patients with intermediate-risk prostate cancer, especially individuals with small, well-defined tumors localized to the lateral and posterior regions of the gland.